Successful Alternative Protein Fund First Close Announced for New Protein Fund II by Big Idea Ventures

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) --

  • Big Idea Ventures, the world’s most active food-tech investor, has made a first close for its New Protein Fund II (NPF II) based on the performance of New Protein Fund I (NPF I).
  • With their second alternative protein fund, New Protein Fund II, Big Idea Ventures will continue to invest in the best alternative protein and ingredients startups around the world, consolidating their position as the global leader in alternative protein technologies.
  • The fund made its first close in May and aims to close the targeted $75M within the next 12 months.

AAK, a multi-oil ingredient house specialized in plant-based vegetable oils and fats, and Bühler, a solution partner for the food processing industry, have joined other investors for the initial funding round. Both companies also invested in Big Idea Ventures' first fund.

Big Idea Ventures is expanding its investment portfolio by including companies that focus on alternative ingredients and impactful food. It also will maintain its current investment thesis in alternative protein innovators by investing in the best plant-based, cell-based and fermentation-enabled alternative protein companies around the world.

Founder Andrew D. Ive said: “With NPF I, we found and worked with companies we believe will become leaders in the alternative protein category. NPF II enables us to bring even more innovators with fantastic innovations and teams in our portfolio. Our mission is to solve the world’s biggest challenges by supporting the world’s best entrepreneurs, scientists and engineers.”

Big Idea Ventures was the first global fund dedicated towards the development and expansion of alternative protein companies and within a few years, quickly became the most active investor in the foodtech category. Numerous noteworthy businesses can be found in NPF's portfolio, such as French startup Gourmey, which secured an impressive €48 million in Series A funding, constituting the largest round ever closed in the world last year. Another great example is Black Sheep Foods, which attained $12.3 million in Series A funding.

NPF II will invest in early-stage startups around the world both through its accelerator program and direct investments. The Big Idea Ventures accelerator program is an intensive five-month program run out of the firm’s Paris, Singapore, and New York offices. The program assists companies in overcoming obstacles to effectively scaling a startup. This is accomplished by providing assistance from internal and external experts, corporate investors, and a broad network of mentors.

"It has truly been a pleasure to provide support to our diverse range of portfolio companies. From tantalizing plant-based meat to sustainable cultivated oysters, as well as innovative seaweed and mycelium-based products, our team has been privileged to witness the growth and development of these exceptional product lines. Currently we are focused on enabling technologies for the industry. We foresee that through NPF II, we will be able to accelerate the industry further with investments in technologies such as molecular farming, precision-fermentation, AI-enabled softwares & hardwares, and more” said Andrew D. Ive.

With this latest close, Big Idea Ventures now has over $100M assets under management.

To find out more about New Protein Fund II and investment opportunities, contact

About Big Idea Ventures
Big Idea Ventures is the world’s most active investor in FoodTech - our goal is to invest in the best food technology and agritech companies globally. The company has contributed to the development of the growing alternative protein industry since its inception and has become a global leader in food innovation. BIV is backed by a strong network of strategic partners including AAK, Avril, Bühler, Givaudan, Temasek Holdings, and Tyson Ventures, and is partnering with governments around the world working on food security and new food ecosystems. The firm has offices in New York, Paris and Singapore and has invested in more than 100 companies across 25 countries. For more information, visit

Media contact:
Olivia Chavassieu,